Tetraphase Pharmaceuticals (TTPH) Target Raised to $46 at Needham & Company
Get Alerts TTPH Hot Sheet
Rating Summary:
6 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 13 | New: 17
Join SI Premium – FREE
Needham & Company analyst Alan Carr reiterated a Buy rating and boosted his price target on Tetraphase Pharmaceuticals (NASDAQ: TTPH) to $46.00 (from $28.00) following positive Phase 3 Eravacycline results in cIAI.
Tetraphase announced positive results yesterday from its Phase 3 trial of IV eravacycline in complicated Intra-abdominal Infections. The trial met its primary non-inferiority endpoint against comparator ertapenem under both FDA and EMA analyses. Point estimates, however, were not disclosed. Mgmt asserted safety profile was generally consistent with prior clinical experience. We expect details to be presented at the ECCMID mtg in Apr 2015. Considering clinical safety and efficacy profile, surveillance data, and IV/oral flexibility, we believe eravacycline will be well-positioned in the Gram-negative space relative to current options, including carbapenems, and other late-stage antibiotics. We assume launch in 2H16. We reiterate our BUY rating and raise our target to $46, based on 25x our $3.68 2020 EPS estimate, discounted 15% annually.
For an analyst ratings summary and ratings history on Tetraphase Pharmaceuticals click here. For more ratings news on Tetraphase Pharmaceuticals click here.
Shares of Tetraphase Pharmaceuticals closed at $33.19 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- VinFast Auto Ltd. (VFS) PT Lowered to $5 at BTIG
- Hancock Whitney (HWC) PT Lowered to $52 at Piper Sandler
- Atos SE (ATO:FP) (AEXAY) PT Lowered to EUR1.70 at CFRA
Create E-mail Alert Related Categories
Analyst Comments, Analyst PT ChangeRelated Entities
Needham & CompanySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!